ArticleJMIR formative research2024
Evaluation of RMES, an Automated Software Tool Utilizing AI, for Literature Screening with Reference to Published Systematic Reviews as Case-Studies: Development and Usability Study.
Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transforming Systematic Reviews: Evaluating a Fine-Tuned Large Language Model for Abstract Screening in Uveitis and Retinal Vasculitis: Fine-Tuned LLM for Review Screening.Ophthalmology science · 2026Article
- Artificial Intelligence Resources for the Screening of Titles and Abstracts in Systematic Reviews: A Scoping Review.Cochrane evidence synthesis and methods · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystematic reviews and meta-analyses are important to evidence-based medicine, but the information retrieval and literature screening procedures are burdensome tasks. Rapid Medical Evidence Synthesis (RMES; Deloitte Tohmatsu Risk Advisory LLC) is a software designed to support information retrieval, literature screening, and data extraction for evidence-based medicine.
objectiveThis study aimed to evaluate the accuracy of RMES for literature screening with reference to published systematic reviews.
methodsWe used RMES to automatically screen the titles and abstracts of PubMed-indexed articles included in 12 systematic reviews across 6 medical fields, by applying 4 filters: (1) study type; (2) study type + disease; (3) study type + intervention; and (4) study type + disease + intervention. We determined the numbers of articles correctly included by each filter relative to those included by the authors of each systematic review. Only PubMed-indexed articles were assessed.
resultsAcross the 12 reviews, the number of articles analyzed by RMES ranged from 46 to 5612. The number of PubMed-cited articles included in the reviews ranged from 4 to 47. The median (range) percentage of articles correctly labeled by RMES using filters 1-4 were: 80.9% (57.1%-100%), 65.2% (34.1%-81.8%), 70.5% (0%-100%), and 58.6% (0%-81.8%), respectively.
conclusionsThis study demonstrated good performance and accuracy of RMES for the initial screening of the titles and abstracts of articles for use in systematic reviews. RMES has the potential to reduce the workload involved in the initial screening of published studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.